Academic Unit of Dermatology Research, Department of Infection and Immunity, Faculty of Medicine, Dentistry and Health, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
Br J Dermatol. 2011 Aug;165(2):329-34. doi: 10.1111/j.1365-2133.2011.10395.x. Epub 2011 Jul 11.
The emollient aqueous cream BP is frequently used for the treatment of atopic dermatitis (AD), yet it is associated with a high rate of adverse cutaneous reactions. It contains the harsh anionic surfactant sodium lauryl sulphate, a known negative environmental factor associated with the exacerbation of AD.
To investigate the effect of aqueous cream BP on stratum corneum (SC) integrity and skin barrier function in volunteers with a predisposition to a defective skin barrier.
Thirteen volunteers with a previous history of AD (no symptoms for 6 months) applied aqueous cream BP twice daily to the volar side of one forearm for 4 weeks. The other forearm was left untreated as a control. Permeability barrier function and SC integrity were determined before and after treatment by measuring transepidermal water loss (TEWL) in conjunction with tape-stripping. For comparison, 13 volunteers with current AD were recruited for assessment, without treatment, of SC integrity and skin barrier function at unaffected sites.
Topical application of aqueous cream BP resulted in significant elevation of baseline TEWL and a concomitant decrease in SC integrity. Measurements made after no treatment in volunteers with current AD, at unaffected sites, suggest that application of aqueous cream BP negatively affects the skin barrier towards the damaged state associated with onset of flares of the disease.
Aqueous cream BP used as a leave-on emollient caused severe damage to the skin barrier in volunteers with a previous history of AD. Aqueous cream BP should not be used as a leave-on emollient in patients with AD.
保湿水性乳膏 BP 常用于治疗特应性皮炎(AD),但它与高不良反应发生率相关。它含有刺激性阴离子表面活性剂月桂醇硫酸钠,这是一种已知的负面环境因素,与 AD 的恶化有关。
研究水性乳膏 BP 对有缺陷皮肤屏障倾向的志愿者的角质层(SC)完整性和皮肤屏障功能的影响。
13 名有 AD 既往病史的志愿者(6 个月无症状)将水性乳膏 BP 每天两次涂抹于一只前臂的屈侧,持续 4 周。另一只前臂作为对照不进行处理。通过测量经皮水分丢失(TEWL)结合胶带剥离,在治疗前后评估 SC 完整性和屏障功能。为了进行比较,招募了 13 名患有 AD 的志愿者,不进行治疗,评估未受影响部位的 SC 完整性和皮肤屏障功能。
局部应用水性乳膏 BP 导致基线 TEWL 显著升高,并伴有 SC 完整性降低。在患有 AD 的志愿者的未受影响部位,不进行治疗后的测量表明,水性乳膏 BP 的应用会使皮肤屏障向与疾病发作相关的受损状态产生负面影响。
作为一种留用型保湿剂,水性乳膏 BP 会对有 AD 既往病史的志愿者的皮肤屏障造成严重损害。AD 患者不应使用水性乳膏 BP 作为留用型保湿剂。